Published in J Immunol on February 19, 2010
Overcoming drug resistance by regulating nuclear receptors. Adv Drug Deliv Rev (2010) 1.10
Sterol regulation of metabolism, homeostasis, and development. Annu Rev Biochem (2011) 1.08
Pregnane X receptor as a target for treatment of inflammatory bowel disorders. Trends Pharmacol Sci (2012) 0.99
Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci (2012) 0.97
Deficiency of PXR decreases atherosclerosis in apoE-deficient mice. J Lipid Res (2011) 0.96
Expression of the PXR gene in various types of cancer and drug resistance. Oncol Lett (2013) 0.94
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. Mar Drugs (2013) 0.78
Novel functions of PXR in cardiometabolic disease. Biochim Biophys Acta (2016) 0.77
The pregnane X receptor in tuberculosis therapeutics. Expert Opin Drug Metab Toxicol (2015) 0.75
Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity. Nucl Receptor Res (2016) 0.75
Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med (2015) 4.60
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol (2006) 4.23
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet (2007) 3.94
Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol (2010) 2.87
Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev (2006) 2.31
Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol (2003) 2.26
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med (2002) 2.07
Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. J Lipid Res (2008) 1.63
Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol (2009) 1.52
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol (2002) 1.49
Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Invest Dermatol (2004) 1.45
IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites. Eur J Immunol (2006) 1.43
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol (2009) 1.43
Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol (2007) 1.41
Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol (2011) 1.41
Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol (2002) 1.25
Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med (2009) 1.24
Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations. J Am Acad Dermatol (2008) 1.23
Epidermal Langerhans cells--changing views on their function in vivo. Immunol Lett (2006) 1.18
A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol (2004) 1.13
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol (2009) 1.10
Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol (2006) 1.08
SOCS-1 and SOCS-3 inhibit IL-4 and IL-13 induced activation of Eotaxin-3/CCL26 gene expression in HEK293 cells. Mol Immunol (2005) 1.07
Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress. J Lipid Res (2002) 1.07
Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther (2013) 1.06
Monocyte-derived dendritic cells release neopterin. J Leukoc Biol (2002) 1.04
Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration. EMBO J (2003) 1.04
Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol (2002) 1.04
Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J Immunol (2011) 1.04
The regulation of permeability barrier homeostasis. J Invest Dermatol (2007) 1.01
Filaggrin mutations p.R501X and c.2282del4 in ichthyosis vulgaris. Eur J Hum Genet (2006) 0.99
Dendritic cells contribute to the development of atopy by an insufficiency in IL-12 production. J Allergy Clin Immunol (2002) 0.97
Isolation of skin dendritic cells from mouse and man. Methods Mol Biol (2010) 0.96
STAT6-dependent and -independent mechanisms in Th2 polarization. Eur J Immunol (2012) 0.95
Conditional targeting of plectin in prenatal and adult mouse stratified epithelia causes keratinocyte fragility and lesional epidermal barrier defects. J Cell Sci (2007) 0.95
The diesel exhaust component pyrene induces expression of IL-8 but not of eotaxin. Int Immunopharmacol (2003) 0.92
Atopic dermatitis: the role of Langerhans cells in disease pathogenesis. Immunol Cell Biol (2010) 0.92
Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP. Blood (2005) 0.91
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep (2009) 0.91
LEF-1 negatively controls interleukin-4 expression through a proximal promoter regulatory element. J Biol Chem (2008) 0.91
IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J Immunol (2003) 0.91
Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol (2002) 0.91
A novel homozygous missense mutation in SLURP1 causing Mal de Meleda with an atypical phenotype. Arch Dermatol (2011) 0.87
Adhesion of dendritic cells derived from CD34+ progenitors to resting human dermal microvascular endothelial cells is down-regulated upon maturation and partially depends on CD11a-CD18, CD11b-CD18 and CD36. Eur J Immunol (2002) 0.87
PPARδ activation promotes stratum corneum formation and epidermal permeability barrier development during late gestation. J Invest Dermatol (2009) 0.85
TLR8 and NOD signaling synergistically induce the production of IL-1β and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2. Immunobiology (2012) 0.85
Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling. J Biol Chem (2010) 0.84
Epiplakin is dispensable for skin barrier function and for integrity of keratin network cytoarchitecture in simple and stratified epithelia. Mol Cell Biol (2006) 0.84
An appraisal of oral retinoids in the treatment of pachyonychia congenita. J Am Acad Dermatol (2011) 0.84
Stabilization of the dimeric birch pollen allergen Bet v 1 impacts its immunological properties. J Biol Chem (2013) 0.84
Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses? Transplantation (2007) 0.83
Peroxisome proliferator-activated receptor-alpha activation inhibits Langerhans cell function. J Immunol (2007) 0.83
Identification of a distal tandem STAT6 element within the CCL17 locus. Hum Immunol (2007) 0.82
Distinguishing ichthyoses by protein profiling. PLoS One (2013) 0.82
The Role of Natural Killer Cells in Humoral Rejection. Transplantation (2015) 0.82
Interferon-gamma-mediated pathways and in vitro PBMC proliferation in HIV-infected patients. Biol Chem (2009) 0.82
Conditioning of the injection site with CpG enhances the migration of adoptively transferred dendritic cells and endogenous CD8+ T-cell responses. J Immunother (2010) 0.82
In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. Nephrol Dial Transplant (2004) 0.80
CD34+ -derived Langerhans cell-like cells are different from epidermal Langerhans cells in their response to thymic stromal lymphopoietin. J Cell Mol Med (2011) 0.80
Patulin influences the expression of Th1/Th2 cytokines by activated peripheral blood mononuclear cells and T cells through depletion of intracellular glutathione. Environ Toxicol (2008) 0.79
Lack of IL-2 in PPAR-α-deficient mice triggers allergic contact dermatitis by affecting regulatory T cells. Eur J Immunol (2011) 0.79
PPAR-alpha in cutaneous inflammation. Dermatoendocrinol (2011) 0.79
Inherited clinical disorders of lipid metabolism. Curr Probl Dermatol (2010) 0.78
Epidermal barrier dysfunction in non-atopic HIV: evidence for an "inside-to-outside" pathogenesis. J Invest Dermatol (2009) 0.78
Concomitant manifestation of pili annulati and alopecia areata: coincidental rather than true association. Acta Derm Venereol (2011) 0.78
Inherited disorders of corneocyte proteins. Curr Probl Dermatol (2010) 0.78
Prognosis of lymphomatoid papulosis. Oncologist (2006) 0.78
Evidence for genetic modifiers other than filaggrin mutations in X-linked ichthyosis. J Dermatol Sci (2010) 0.78
Characterization of Small Marker Chromosomes (SMC) by Recently Developed Molecular Cytogenetic Approaches. J Assoc Genet Technol (2003) 0.78
(P)PARsing epidermal development. J Invest Dermatol (2006) 0.77
The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy. J Pathol (2014) 0.76
Lower prevalence of common filaggrin mutations in a community sample of atopic eczema: is disease severity important? Wien Klin Wochenschr (2010) 0.76
Focuses solely on generalized, inherited (Mendelian) disorders of cornification (DOC or MeDOC). Introduction. Curr Probl Dermatol (2010) 0.76
Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells. Clin Immunol (2009) 0.76
Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors. Exp Dermatol (2014) 0.75
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria. Acta Derm Venereol (2016) 0.75
[Pitfalls in diagnosis and treatment of cutaneous larva migrans: three unusual cases from a dermatology clinic]. Wien Klin Wochenschr (2013) 0.75
Inherited disorders of accelerated desquamation. Curr Probl Dermatol (2010) 0.75
Parameters of soluble immune activation in vivo correlate negatively with the proliferative capacity of peripheral blood mononuclear cells in vitro in HIV-infected patients. J Acquir Immune Defic Syndr (2009) 0.75
Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides. Acta Derm Venereol (2005) 0.75